Shkreli wants to ‘berate’ Congress, but will take the Fifth

CP36239084
Former Turing Pharmaceuticals CEO Martin Shkreli is interviewed by host Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York, Tuesday, Feb. 2, 2016. (AP Photo/Richard Drew)

NEW YORK, N.Y. – Former pharmaceutical CEO Martin Shkreli says he’d like to “berate” and “insult” Congress — but instead will take the Fifth Amendment during questioning on Thursday.

The former Turing Pharmaceuticals CEO, who’s reviled for hiking the price of a lifesaving drug, spoke Tuesday on Fox Business.

Shkreli said that instead of invoking his right against self-incrimination, as planned, he would “love to talk to Congress.” He says he would “berate them” and “insult them.”

Meanwhile, his new lawyer, Benjamin Brafman, issued a statement expressing confidence that Shkreli will be exonerated in his federal court case. He’ll have a routine court appearance Wednesday in New York.

In December, the former hedge fund manager was charged with securities fraud and conspiracy related to another pharmaceutical company he previously ran, Retrophin.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles